Technology firm GenIP has expanded into the Republic of Chile through an engagement for 30 analytical assessment orders from a leading research institution.
Source: Sharecast
GenIP said on Tuesday that the order has increased the total value of Invention Evaluator orders received since its IPO in October 2024 to more than $850,000.
Chief executive Melissa Cruz said: "I am delighted to announce another new international contract with a leading research university, marking GenIP's first entry into the Chilean market. The institution has purchased 30 Invention Evaluator assessments, to support technology commercialisation decisions across its research portfolio.
"GenIP's global expansion is underpinned by a healthy balance sheet that allows the company to capitalise on opportunities as they arise."
As of 0835 BST, GenIP shares were 7.11% higher at 28.92p.
Reporting by Iain Gilbert at Sharecast.com
N/A
ISIN:
N/A
Exchange: N/A
Sell:
N/A
Buy:
N/A
Change:
Date:
Prices delayed by at least 15 minutes
Compare our accounts
If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.
Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.
